Trial Profile
A Study to Evaluate the Osteoclastogenesis and Osteoblastogenesis in Peripheral Blood after TNF Blocker Treatment in Seropositive Rheumatoid Arthritis (RA) Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 11 Feb 2016 New trial record